SQSTM1 and nasopharyngeal carcinoma: Furthermore, multiple studies reported that SQSTM1 could serve as a novel prognostic biomarker in multiple cancers types, including nasopharyngeal carcinoma, lung cancer, oral squamous cell carcinoma, and HCC [38–41].